{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:24:52Z","timestamp":1774538692901,"version":"3.50.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,5]]},"DOI":"10.7759\/cureus.93864","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T13:42:32Z","timestamp":1759671752000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Primary Malignant Peritoneal Mesothelioma"],"prefix":"10.7759","author":[{"given":"Liz","family":"Betancourt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Sugarman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryant","family":"Estevez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"La Roz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evert","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian","family":"Casadesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14605","article-title":"Malignant pleural mesothelioma epidemiology in the United States from 2000 to 2016","volume":"13","author":"Thomas A","year":"2021","unstructured":"Thomas A, Karakattu S, Cagle J, Hoskere G. Malignant pleural mesothelioma epidemiology in the United States from 2000 to 2016. Cureus. 2021, 13:e14605. 10.7759\/cureus.14605","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5804230","article-title":"Complex immune Contextures characterise malignant peritoneal mesothelioma: loss of adaptive immunological signature in the more aggressive histological types","author":"Tazzari M","year":"2018","unstructured":"Tazzari M, Brich S, Tuccitto A, et al.. Complex immune Contextures characterise malignant peritoneal mesothelioma: loss of adaptive immunological signature in the more aggressive histological types. J Immunol Res. 2018, 5804230. 10.1155\/2018\/5804230","journal-title":"J Immunol Res"},{"key":"ref3","article-title":"Malignant peritoneal mesothelioma: a review","author":"Broeckx G","year":"2018","unstructured":"Broeckx G, Pauwels P. Malignant peritoneal mesothelioma: a review. Transl Lung Cancer Res. 2018, 537-542.","journal-title":"Transl Lung Cancer Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3803-6","article-title":"Current trends in the management of malignant peritoneal mesothelioma","volume":"21","author":"Miura JT","year":"2014","unstructured":"Miura JT, Johnston FM, Gamblin TC, Turaga KK. Current trends in the management of malignant peritoneal mesothelioma. Ann Surg Oncol. 2014, 21:3947-53. 10.1245\/s10434-014-3803-6","journal-title":"Ann Surg Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2020.07.001","article-title":"The staging of malignant pleural mesothelioma","volume":"30","author":"Euhus CJ","year":"2020","unstructured":"Euhus CJ, Ripley RT. The staging of malignant pleural mesothelioma. Thorac Surg Clin. 2020, 30:425-33. 10.1016\/j.thorsurg.2020.07.001","journal-title":"Thorac Surg Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010229","article-title":"Contemporary trends in malignant peritoneal mesothelioma: incidence and survival in the United States","volume":"15","author":"Calthorpe L","year":"2022","unstructured":"Calthorpe L, Romero-Hernandez F, Miller P, et al.. Contemporary trends in malignant peritoneal mesothelioma: incidence and survival in the United States. Cancers (Basel). 2022, 15:229. 10.3390\/cancers15010229","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas P","year":"2021","unstructured":"Baas P, Scherpereel A, Nowak A, et al.. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet. 2021, 397:P375-86. 10.1016\/S0140-6736(20)32714-8","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/329878-a-case-of-primary-malignant-peritoneal-mesothelioma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T13:42:33Z","timestamp":1759671753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/329878-a-case-of-primary-malignant-peritoneal-mesothelioma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,5]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.93864","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,5]]}}}